Navigation Links
LeClairRyan Adds Three Veteran Venture Capital Attorneys to San Francisco Office
Date:4/28/2011

SAN FRANCISCO, April 28, 2011 /PRNewswire/ -- LeClairRyan is pleased to announce the addition of three veteran venture capital attorneys to its San Francisco office.  Joining the firm in the corporate department are Eric K. Ferraro, Jeffrey T. Drake, and Jonathan T. Rubens, formerly of Bullivant Houser Bailey.

"We are excited to have Eric, Jeff and Jon join us," said San Francisco office leader Peter M. Hart.  "With their addition we are gaining significant legal experience and technology industry know-how, as well as expanding the depth and breadth of the corporate services we provide to clients in San Francisco."

Ferraro, who joins LeClairRyan as a shareholder, focuses his practice on the representation of private and public emerging and growth companies in the technology and digital media sectors as well as investors and financial services firms that focus on those industries. He advises clients in matters relating to entity formation and founder arrangements, corporate governance, seed and venture capital financing, employment and equity compensation, intellectual property protection, technology licensing and product distribution, mergers and acquisitions, public offerings, and SEC reporting and compliance.  He also has significant experience in executive compensation transactions, often representing CEOs and executive teams in high-value mergers and acquisitions.  Ferraro is a graduate of the Golden Gate University School of Law (J.D.) and the University of Vermont (B.A.).  

"With the addition of this West Coast team, LeClairRyan has added depth and important geographic reach to our representation of start-up and high growth companies," said Michael P. Drzal, leader of the firm's Venture Capital Practice Area Team.  "In addition to their depth of legal experience, technology industry knowledge, market awareness and business acumen, our San Francisco venture team brings with them a wealth of valuable connect
'/>"/>

SOURCE LeClairRyan
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
2. FDA Extends Review Timeline for Ustekinumab Biologic License Application Three Months
3. American Laser Centers Opens Three Minneapolis-St. Paul Area Clinics
4. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
5. ViroPharma to Present at Three September Healthcare Conferences
6. Spherics, Inc. Presented Three Key Technologies (BIOROD(TM), BIOGIT(TM), and SPHEROMER(TM)) at the 35th Annual Meeting of Controlled Release Society
7. TorreyPines Therapeutics Strategically Repositions as Development Company Focusing on Three Versatile Lead Compounds
8. ViroPharma to Present at Three October Healthcare Conferences
9. Cell Therapeutics, Inc. (CTI) to Present at Three Upcoming Investor Conferences
10. Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years
11. NicOx Reports Results for the First Three Quarters of 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... and OSAKA, Japan ... Cell Research Application (CiRA) of Kyoto University and ... they will work together to develop clinical applications ... as heart failure, diabetes mellitus, neurological disorders and ... Cell Applications" (T-CiRA) is designed to expedite multiple ...
(Date:4/16/2015)... 2015 Proove Biosciences , Inc. ... BIO Contest for the 2015 BIO International Convention. ... BIO International Convention will take place June 15-18 at ... Buzz of BIO contest, industry leaders will be voting ... the conference. The community voting period began on April ...
(Date:4/16/2015)... OncoTAb, Inc., a University ... company, announced today the appointment of physician and ... Operating Officer (COO). Cooper brings to OncoTAb more ... diagnostic and biotechnology platforms in the fields of ... career transcends the field of medical and scientific ...
(Date:4/16/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... venture with G-treeBNT (ReGenTree LLC) has retained Ora, ... for the orphan disorder, neurotrophic keratopathy (NK), and ... syndrome (DES) in the U.S.  Both trials will ... year.  Each of these eye disorders was being ...
Breaking Biology Technology:CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 3Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3OncoTAb Names Dr. David L. Cooper as COO 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
... , , SUNNYVALE, Calif., July ... endovascular devices for the treatment of chronic total occlusions (CTOs), today ... Operating Officer. Chris previously held the position of Executive VP, Sales ... in Medical Devices including the last 2 years at FlowCardia. , ...
... LONG BRANCH, N.J., July 23 The 2009 Pharma ... the current 500 attendees and 100 exhibitors have been posted ... Alexay of Apaporis LLC, the event organizer. Attendance is ... 2008,s record turnout. One thousand attendees are expected on ...
... , SEATTLE, July 23 Cell Therapeutics, Inc. (Nasdaq ... of an underwritten public offering of 29,332,107 shares of its common ... common stock at a price to the public of $1.30 per ... common stock, for gross proceeds of approximately $38.1 million. In ...
Cached Biology Technology:FlowCardia, Inc. Appoints Chris Barys to Chief Operating Officer 2ChemOutsourcing Unveils 2009 Attendee List for September Show in New Jersey 2Cell Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants 2Cell Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants 3
(Date:3/19/2015)... , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, announces its biometric ... news clip that aired this week on Washington ... In a segment "The Next Great Thing", host ... new way to pay, and ,a really big breakthrough in ...
(Date:3/17/2015)... , March 17, 2015 MedNet ... specializing in clinical study management systems, is pleased ... attendance at ARENA,s Outsourcing in Clinical Trials Southeast ... event provides an excellent forum for MedNet to ... and affordable software-as-a-service (SaaS) eClinical technology platform. ...
(Date:3/17/2015)... 2015  MecklerMedia Corporation (OTCQX: MECK) announced its ... robots ever held in New York ... 11-13, 2015 at the Javits Convention Center. ... include: Acorn Product Development; Axis NJ; c-Link Systems; ... Littler; NewBotic Corporation; Neya Systems LLC; Reliabotics; RoboKind; ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... crop in states such as Massachusetts, Wisconsin, New Jersey, ... problems for growers trying to realize profits in heavy ... pest damage can have a particularly significant negative impact ... feeding preferences of insects, entomologists have reported that several ...
... , JERUSALEM, ISRAEL, June 22, 2011 Ben-Gurion University ... most comprehensive report to date on Israel,s environmental movement. ... experts and public support, as well as its perilous ... Movement: Trends, Needs and Potential," was presented to Knesset ...
... Evolution is usually thought to be a very ... to adaptive mutations. But environmental change due to things ... very fast. There are just two options for species ... become extinct. So, according to McGill biology professor, ...
Cached Biology News:Pest preferences for cranberry cultivars determined 2Ben-Gurion University team presents environment movement report to Israel's Knesset 2Ben-Gurion University team presents environment movement report to Israel's Knesset 3Evolution to the rescue 2
... for ChIP assays. Efficient fixation of a ... crucial step for the Chromatin-immunoprecipitation (ChIP) technique. ... most important parameter. Two major problems concerning ... into account: first, an excess of crosslinking ...
Mouse monoclonal antibody to ANAPC2 - anaphase promoting complex subunit 2...
Handy 100V Power Supply is Low-cost, compact and lightweight. Easy to operate - either 50 or 100 VDC is selectable as the output voltage. These voltages are sufficient for ordinary electrophoresis....
Rabbit polyclonal to Synapsin II ( Abpromise for all tested applications). entrezGeneID: 6854 SwissProtID: Q92777...
Biology Products: